Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMAXIM : revenue, balance sheet and financial ratios

PHARMAXIM is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in COMPIEGNE (60200), this company of category PME shows in 2025 a net income positive of 19 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMAXIM (SIREN 532614294)
Indicator 2025 2024 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 18 571 € 48 258 € -11 448 € 14 573 € 15 041 € 74 053 € 63 326 € 52 643 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

Im Jahr 2025 erzielt PHARMAXIM ein positives Nettoergebnis von 19 k€. Entwicklung 2017-2025: 53 k€ -> 19 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

18 571 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 73%. Der Verschuldungsgrad ist hoch: Der Verhandlungsspielraum mit Banken ist reduziert. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 48%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

72.502%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

47.756%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.3%

Solvency indicators evolution
PHARMAXIM

Sector positioning

Verschuldungsgrad
72.5 2025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average -6 pts over 3 years

Im Jahr 2025 liegt über dem Median der Branche das verschuldungsgrad von PHARMAXIM (72.50). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.

Finanzielle Autonomie
47.76% 2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average +12 pts over 3 years

Im Jahr 2025 liegt unter dem Median der Branche das finanzielle autonomie von PHARMAXIM (47.8%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Eine Verbesserung würde die Wettbewerbsposition stärken.

Liquidity ratios

Die Liquiditätsquote beträgt 118.37. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

118.37

Liquidity indicators evolution
PHARMAXIM

Sector positioning

Liquiditätsquote
118.37 2025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Beobachten

Im Jahr 2025 liegt in den unteren 25% der Branche das liquiditätsquote von PHARMAXIM (118.37). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.

Positioning of PHARMAXIM in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMAXIM is estimated at 295 002 € (range 200 190€ - 462 899€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
200k€ 295k€ 462k€
295 002 € Range: 200 190€ - 462 899€
NAF 5 année 2025

Valuation method used

Net Income Multiple
18 571 € × 15.9x = 295 003 €
Range: 200 190€ - 462 900€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMAXIM with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMAXIM

What is the revenue of PHARMAXIM ?

The revenue of PHARMAXIM is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMAXIM profitable?

Yes, PHARMAXIM generated a net profit of 19 k€ in 2025.

Where is the headquarters of PHARMAXIM ?

The headquarters of PHARMAXIM is located in COMPIEGNE (60200), in the department Oise.

Where to find the tax return of PHARMAXIM ?

The tax return of PHARMAXIM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMAXIM operate?

PHARMAXIM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.